Bifico Relieves Irritable Bowel Syndrome By Regulating Gut Microbiota Dysbiosis and Inflammatory Cytokines in an Animal Model

Yanlin Zhou(Zhejiang Chinese Medical University), Bin Lü(Zhejiang Chinese Medical University)

Research Square

July 26, 2021

10.21203/rs.3.rs-717837/v1

Cited by 0

Related Papers

Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines

|European Journal of Nutrition|2022|53

Effects of nNOS inhibition on the Escherichia coli and butyrate-producing bacteria in IBS rats with visceral hypersensitivity

|Research Square|2023|3

Dysregulated Glycerophospholipid Metabolism and ChAT Overexpression in Wrap-Restraint Stress-Induced IBS Mice: A Multi-Omics Approach to Gut-Brain Axis Disruption and Potential Therapeutic Targets

|Research Square|2023|2